This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Yousef Najareh: Innovator in Nanoparticle Technology
Introduction
Yousef Najareh is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of nanoparticle technology, particularly in the delivery of nucleic acids into living cells. His innovative work has the potential to advance pharmaceutical applications and improve therapeutic outcomes.
Latest Patents
Yousef Najareh holds a patent for "Nanoparticles containing polymeric nucleic acid homologs." This invention describes a nanoparticle capable of delivering an encapsulated molecule into a living cell. The nanoparticle includes an encapsulation media and an isolated nucleic acid homolog sequence. The encapsulation media is primarily polymeric, allowing for the extended release of the encapsulated molecule over time. Additionally, the patent discloses pharmaceutical compositions and methods for preparing and using these nanoparticles.
Career Highlights
Yousef Najareh is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore and develop cutting-edge technologies in the field of nanomedicine. His research focuses on enhancing the efficacy of drug delivery systems through innovative nanoparticle designs.
Collaborations
Yousef has collaborated with notable colleagues, including Gershon Golomb and Haigt Sacks. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further advancing the field of nanoparticle research.
Conclusion
Yousef Najareh's contributions to nanoparticle technology exemplify the innovative spirit of modern science. His work not only enhances our understanding of drug delivery systems but also paves the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
